Literature DB >> 26719332

Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.

Filsy Samuel1, William P Flavin2, Sobia Iqbal1, Consiglia Pacelli3, Sri Dushyaanthan Sri Renganathan1, Louis-Eric Trudeau3, Edward M Campbell4, Paul E Fraser5, Anurag Tandon6.   

Abstract

Although trace levels of phosphorylated α-synuclein (α-syn) are detectable in normal brains, nearly all α-syn accumulated within Lewy bodies in Parkinson disease brains is phosphorylated on serine 129 (Ser-129). The role of the phosphoserine residue and its effects on α-syn structure, function, and intracellular accumulation are poorly understood. Here, co-expression of α-syn and polo-like kinase 2 (PLK2), a kinase that targets Ser-129, was used to generate phosphorylated α-syn for biophysical and biological characterization. Misfolding and fibril formation of phosphorylated α-syn isoforms were detected earlier, although the fibrils remained phosphatase- and protease-sensitive. Membrane binding of α-syn monomers was differentially affected by phosphorylation depending on the Parkinson disease-linked mutation. WT α-syn binding to presynaptic membranes was not affected by phosphorylation, whereas A30P α-syn binding was greatly increased, and A53T α-syn was slightly lower, implicating distal effects of the carboxyl- on amino-terminal membrane binding. Endocytic vesicle-mediated internalization of pre-formed fibrils into non-neuronal cells and dopaminergic neurons matched the efficacy of α-syn membrane binding. Finally, the disruption of internalized vesicle membranes was enhanced by the phosphorylated α-syn isoforms, a potential means for misfolded extracellular or lumenal α-syn to access cytosolic α-syn. Our results suggest that the threshold for vesicle permeabilization is evident even at low levels of α-syn internalization and are relevant to therapeutic strategies to reduce intercellular propagation of α-syn misfolding.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Parkinson disease; endocytosis; fibril; post-translational modification (PTM); protein kinase; protein misfolding; protein self-assembly; vesicles

Mesh:

Substances:

Year:  2015        PMID: 26719332      PMCID: PMC4813466          DOI: 10.1074/jbc.M115.705095

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.

Authors:  Philipp J Kahle; Manuela Neumann; Laurence Ozmen; Veronika Muller; Helmut Jacobsen; Will Spooren; Babette Fuss; Barbara Mallon; Wendy B Macklin; Hideo Fujiwara; Masato Hasegawa; Takeshi Iwatsubo; Hans A Kretzschmar; Christian Haass
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

2.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

3.  Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.

Authors:  Katerina E Paleologou; Adrian W Schmid; Carla C Rospigliosi; Hai-Young Kim; Gonzalo R Lamberto; Ross A Fredenburg; Peter T Lansbury; Claudio O Fernandez; David Eliezer; Markus Zweckstetter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

4.  Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation.

Authors:  Li Chen; Magali Periquet; Xu Wang; Alessandro Negro; Pamela J McLean; Bradley T Hyman; Mel B Feany
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

5.  Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.

Authors:  Kelvin C Luk; Cheng Song; Patrick O'Brien; Anna Stieber; Jonathan R Branch; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

6.  The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.

Authors:  Oleg S Gorbatyuk; Shoudong Li; Layla F Sullivan; Weijun Chen; Galina Kondrikova; Fredric P Manfredsson; Ronald J Mandel; Nicholas Muzyczka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

Review 7.  α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.

Authors:  Katrin Beyer; Aurelio Ariza
Journal:  Mol Neurobiol       Date:  2012-08-25       Impact factor: 5.590

8.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

9.  Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.

Authors:  Wanli W Smith; Russell L Margolis; Xiaojie Li; Juan C Troncoso; Michael K Lee; Valina L Dawson; Ted M Dawson; Takashi Iwatsubo; Christopher A Ross
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.709

10.  Exogenous α-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release.

Authors:  Giuseppe Ronzitti; Giovanna Bucci; Marco Emanuele; Damiana Leo; Tatyana D Sotnikova; Liudmila V Mus; Camille H Soubrane; Mark L Dallas; Agnes Thalhammer; Lorenzo A Cingolani; Sumiko Mochida; Raul R Gainetdinov; Gary J Stephens; Evelina Chieregatti
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

View more
  49 in total

1.  Synj1 haploinsufficiency causes dopamine neuron vulnerability and alpha-synuclein accumulation in mice.

Authors:  Ping-Yue Pan; Patricia Sheehan; Qian Wang; Xinyu Zhu; Yuanxi Zhang; Insup Choi; Xianting Li; Jacqueline Saenz; Justin Zhu; Jing Wang; Farida El Gaamouch; Li Zhu; Dongming Cai; Zhenyu Yue
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

Review 2.  The role of lipids in α-synuclein misfolding and neurotoxicity.

Authors:  Cathryn L Ugalde; Victoria A Lawson; David I Finkelstein; Andrew F Hill
Journal:  J Biol Chem       Date:  2019-05-07       Impact factor: 5.157

3.  Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.

Authors:  Richard J Karpowicz; Conor M Haney; Tiberiu S Mihaila; Raizel M Sandler; E James Petersson; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2017-06-13       Impact factor: 5.157

Review 4.  Transmission of α-synuclein seeds in neurodegenerative disease: recent developments.

Authors:  Richard J Karpowicz; John Q Trojanowski; Virginia M-Y Lee
Journal:  Lab Invest       Date:  2019-02-13       Impact factor: 5.662

5.  Phosphorylation by protein kinase A disassembles the caspase-9 core.

Authors:  Banyuhay P Serrano; Jeanne A Hardy
Journal:  Cell Death Differ       Date:  2018-01-19       Impact factor: 15.828

6.  E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.

Authors:  Ignacio Íñigo-Marco; Miguel Valencia; Laura Larrea; Ricardo Bugallo; Mikel Martínez-Goikoetxea; Iker Zuriguel; Montserrat Arrasate
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-12       Impact factor: 11.205

7.  A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Hua Wang; Tessandra Stewart; Jon B Toledo; Carmen Ginghina; Lu Tang; Anzari Atik; Patrick Aro; Leslie M Shaw; John Q Trojanowski; Douglas R Galasko; Steven Edland; Poul H Jensen; Min Shi; Jing Zhang
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils.

Authors:  Rose B Creed; Matthew S Goldberg
Journal:  Neuroscience       Date:  2020-04-27       Impact factor: 3.590

9.  α-Synuclein aggregation nucleates through liquid-liquid phase separation.

Authors:  Soumik Ray; Nitu Singh; Rakesh Kumar; Komal Patel; Satyaprakash Pandey; Debalina Datta; Jaladhar Mahato; Rajlaxmi Panigrahi; Ambuja Navalkar; Surabhi Mehra; Laxmikant Gadhe; Debdeep Chatterjee; Ajay Singh Sawner; Siddhartha Maiti; Sandhya Bhatia; Juan Atilio Gerez; Arindam Chowdhury; Ashutosh Kumar; Ranjith Padinhateeri; Roland Riek; G Krishnamoorthy; Samir K Maji
Journal:  Nat Chem       Date:  2020-06-08       Impact factor: 24.427

Review 10.  Proteolytic α-Synuclein Cleavage in Health and Disease.

Authors:  Alexandra Bluhm; Sarah Schrempel; Stephan von Hörsten; Anja Schulze; Steffen Roßner
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.